On September 18th, the WSU Innovation Open House, a “special showcase of just a small sample of the many research activities at Washington State University” was held in the CUB to correspond with the WSU Foundation Annual Meeting of the Board of Trustees. From projects just past proof-of-concept to innovations well under way to their commercialization, the showcase demonstrated not only the efforts of the researchers, but the OC’s contributions as well. Here’s a brief presentation of the projects in attendance:
The Washington Biotechnology and Biomedical Association recently highlighted the Washington State University Office of Commercialization and its partnership with Accelerator. In discussing the OC’s history, the WBBA briefly discussed our recent partnership with the biotech investment company, and also explained a few of our other programs coinciding with our push for WSU’s revitalization of the commercialization departments.
Read more on the story here: http://www.washbio.org/?page=WSU_Accelerator
The Washington State University Office of Commercialization is proud to announce that M3 Biotechnology, one of our local startup companies, has been selected as one of five companies to be showcased by the Michael J. Fox Foundation for their work on neurodegenerative disease therapies. The MJFF aims to accelerate the research and development of projects in Parkinson’s disease research by making the researchers and projects more visible.
M3 Biotechnology’s mission statement, ‘To cure neurodegenerative diseases’ is a straightforward explanation of their goals and projects. The group was already supported from grants from the MJFF as well as the Alzheimer’s Drug Discovery foundation, groups highly interested … » More …